Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 62, 2002 - Issue 5
Submit an article Journal homepage
14
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Rapid simultaneous genotyping of the frequent butyrylcholinesterase variants Asp70Gly and Ala539Thr with fluorescent hybridization probes

M. R. Gätke Danish Cholinesterase Research Unit, Department of Anaesthesia, Center of Head and Orthopaedics and the Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Denmark
,
J. Viby-Mogensen Danish Cholinesterase Research Unit, Department of Anaesthesia, Center of Head and Orthopaedics and the Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Denmark
&
J. R. Bundgaard Danish Cholinesterase Research Unit, Department of Anaesthesia, Center of Head and Orthopaedics and the Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Denmark
Pages 375-383 | Published online: 08 Jul 2009

  • Viby-Mogensen J. Correlation of succinylcholine duration of action with plasma cholinesterase activity in subjects with the genotypically normal enzyme. Anesthesiology 1980; 53:517-20.
  • Østergaard D, Jensen FS, Jensen E, Skovgaard LT, Viby-Mogensen J. Influence of plasma cholinesterase activity on recovery from mivacuriuminduced neuromuscular blockade in phenotypically normal patients. Acta Anaesthesiol Scand 1992; 36:702-6.
  • Goudsouzian NG, d'Hollander AA, VibyMogensen J. Prolonged neuromuscular block from mivacurium in two patients with cholinesterase deficiency. Anesth Analg 1993; 77:183-5.
  • Gatke MR, Ostergaard D, Bundgaard JR, Varin F, Viby-Mogensen J. Response to mivacurium in a patient compound heterozygous for a novel and a known silent mutation in the butyrylcholinesterase gene: genotyping by sequencing Anesthesiology 2001; 95:600-6.
  • Vanlinthout LE, Bartels CF, Lockridge O, Callens K, Booij LH. Prolonged paralysis after a test dose of mivacurium in a patient with atypical serum cholinesterase. Anesth Analg 1998; 87:1199-202.
  • Jensen FS, Skovgaard LT, Viby-Mogensen J. Identification of human plasma cholinesterase variants in 6688 individuals using biochemical analysis. Acta Anaesthesiol Scand 1995; 39: 15762.
  • Jensen FS, Viby-Mogensen J. Plasma cholinesterase and abnormal reaction to succinylcholine: twenty years' experience with the Danish Cholinesterase Research Unit. Acta Anaesthesiol Scand 1995; 39:150-6.
  • Whittaker M Cholinesterases, Basel: Karger; 1986.
  • Bartels CF, Jensen FS, Lockridge O, van der Spek AFL, Rubinstein HM, Lubrano T, La Du BN. DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am J Hum Genet 1992; 50:1086-103.
  • Gaffney D, Campbell RA. A PCR based method to determine the Kalow allele of the cholinesterase gene: the Elk allele frequency and its significance in the normal population. J Med Genet 1994; 31:248-50.
  • Jensen FS, Nielsen LR, Schwartz M. Detection of the plasma cholinesterase K variant by PCR using an amplification-created restriction site. Hum Hered 1996; 46:26-31.
  • Evans RT, Wardell J. On the identification and frequency of the J and K cholinesterase phenotypes in a Caucasian population. J Med Genet 1984;21:99-102.
  • Jensen FS, Viby-Mogensen J. Reaction to succinylcholine in two patients segregating for the plasma cholinesterase allele Ek. Acta Anaesthesiol Scand 1992; 36:753-7.
  • Lehmann DJ, Johnston C, Smith AD. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. Hum MoI Genet 1997; 6:1933-6.
  • Panegyres PK, Mamotte CD, Vasikaran SD, Wilton S, Fabian V, Kakulas BA. Butyrycholinesterase K variant and Alzheimer's disease. J Neural 1999; 246:369-70.
  • Wiebusch H, Poirier J, Sevigny P, Schappert K. Further evidence for a synergjstic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease. Hum Genet 1999; 104:158-63.
  • Yamamoto Y, Yasuda M, Mori E, Maeda K. Failure to confirm a synergistic effect between the K-variant of the butyrylcholinesterase gene and the epsilon4 allele of the apolipoprotein gene in Japanese patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry 1999; 67:94-6.
  • Ki CS, Na DL, Kirn JW, Kirn HJ, Kirn DK, Yoon BK. No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease. Am J Med Genet 1999; 88:113-5.
  • Crawford F, Fallin D, Suo Z, Abdullah L, Gold M, Gauntlett A, Duara R, Mullan M. The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations. Neurosci Lett 1998; 249:115-8.
  • Wittwer CT, Ririe KM, Andrew RV, David DA, Gundry RA, Balis UJ. The LightCycler a microvolume multisample fluorimeter with rapid temperature control. Biotechniques 1997; 22: 17681.
  • de Suva D, Wittwer CT. Monitoring hybridization during polymerase chain reaction. J Chromatogr B Biomed Sei Appl 2000; 741:3-13.
  • Wittwer CT, Herrmann MG, Moss AA, Rasmussen RP. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 1997; 22:130-8.
  • Ririe KM, Rasmussen RP, Wittwer CT. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal Biochem 1997; 245:154-60.
  • Arpagaus M, Kott M, Vatsis KP, Bartels CF, La Du BN, Lockridge O. Structure of the gene for human butyrylcholinesterase. Evidence for a single copy. Biochemistry 1990; 29:124-31.
  • Lockridge O, Masson P. Pesticides and susceptible populations: people with butyrylcholinesterase genetic variants may be at risk. Neurotoxicology 2000; 21:113-26.
  • 0stergaard D, Rasmussen SN, Viby-Mogensen J, Pedersen NA, Boysen R. The influence of druginduced low plasma cholinesterase activity on the pharmacokinetics and pharmacodynamics of mivacurium. Anesthesiology 2000; 92:1581-7.
  • Bang U, Viby-Mogensen J, Wiren JE. The effect of bambuterol on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in subjects heterozygous for abnormal plasma cholinesterase. Acta Anaesthesiol Scand 1990; 34:600-4.
  • Davies P, Landy M. Suxamethonium and mivacurium sensitivity from pregnancy-induced plasma cholinesterase deficiency. Anaesthesia 1998; S3:1109-11.
  • Østergaard D, Jensen FS, Jensen E, Skovgaard LT, Viby-Mogensen J. Mivacurium-induced neuromuscular blockade in patients with atypical plasma cholinesterase. Acta Anaesthesiol Scand 1993; 37:314-8.
  • Rubinstein HM, Dietz AA, Lubrano T. Elk, another quantitative variant at cholinesterase locus 1. J Med Genet 1978; 15:27-9.
  • Mcllroy SP, Crawford VL, Dynan KB, McGleenon BM, Vahidassr MD, Lawson JT, Passmore AP. Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland. J Med Genet 2000; 37:182-5.
  • Hashim Y, Shepherd D, Wiltshire S, Holman RR, Levy JC, Clark A, Cull CA. Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects. Diabetologia 2001; 44:2227-30.
  • Clegg RM. Fluorescence resonance energy transfer. Curr Opin Biotechnd 1995; ft 103-10.
  • Bernard PS, Pritham GH, Wittwer CT. Color multiplexing hybridization probes using the apolipoprotein E locus as a model system for genotyping. Anal Biochem 1999; 273:221-8.
  • Hermann MG, Dobrowolski SF, Wittwer CT. Rapid beta-globin genotyping by multiplexing probe melting temperature and color. Clin Chem 2000; 46:425-8.
  • von Ahsen N, Oellerich M, Schutz E. Use of two reporter dyes without interference in a single-tube rapid-cycle PCR: alpha(l)-antitrypsin genotyping by multiplex real-time fluorescence PCR with the LightCycler. Clin Chem 2000; 46:156-61.
  • van den Bergh FAJTM, van Oeveren-Dybicz AM, Bon MAM. Rapid single-tube genotyping of the factor V Leiden and prothrombin mutations by real-time PCR using dual-color detection Clin Chem 2000; 46:1191-5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.